Taliglucerase alfa

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTaliglucerase alfa
Drug Alias NameTaliglucerase α他利西酶α他立苷酶αpGlcCeraseTaliglucerase alpha +[13] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of Actionglucocerebroside hydrolysis activatorsGlucosylceramidase replacements
TargetsGlucosylceramide
Therapy Area/IndicationsGaucher Disease
Global Approved IndicationsGaucher Disease
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2012/05/01
Country/TerritoryCanadaUnited StatesParaguay +[11] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesProtalix Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesProtalix Biotherapeutics IncPfizer Inc
Inactive CompaniesProtalixPfizer Ltd
Active IndicationsGaucher Disease
Inactive IndicationsN/A

Other Information

ATC CodeA16AB11
Related LinksWikipediaDrugBankKEGG